Literature DB >> 33607839

Hybrid operation for infectious thoracic and abdominal aortic aneurysms complicated with Bacillus Calmette-Guérin therapy for bladder cancer: A case report.

Kentaro Akabane1, Tetsuro Uchida2, Somei Matsuo1, Shuto Hirooka1, Cholus Kim1, Hideaki Uchino1, Takao Shimanuki1.   

Abstract

RATIONAL: Bacillus Calmette-Guérin (BCG) intravesical instillation therapy is a widely used treatment for bladder cancer; however, an infectious aneurysm has been reported as a rare complication. PATIENT CONCERNS: A 76-year-old man who underwent BCG intravesical instillation therapy for bladder cancer presented with prolonged dull back pain for 3 months. DIAGNOSIS: Computed tomography (CT) revealed both thoracic and abdominal aortic aneurysms (AAAs). Follow-up CT at 4 weeks after the initial examination showed rapid enlargement of both aneurysms and typical findings of inflammation. Therefore, he was diagnosed with an impending rupture of infectious aneurysms.
INTERVENTIONS: Although open surgical resection of both aneurysms and vascular reconstruction were ideal, these operations were considered highly invasive for the patient. Therefore, a hybrid operation consisting of simultaneous endovascular repair of the thoracic aneurysm and open surgery of the abdominal lesion was performed. OUTCOMES: BCG "Tokyo-172" strain was identified in the resected sample from the aneurysmal wall, and he continued to receive oral antituberculosis drugs for 6 months. No sign of recurrent infection was observed 1 year after the operation. LESSONS: A hybrid operation might be justified as an alternative to the conventional open surgical procedure, especially for patients with infectious aneurysms caused by weak pathogenic bacteria such as, the BCG mycobacteria.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33607839      PMCID: PMC7899839          DOI: 10.1097/MD.0000000000024796

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  12 in total

1.  The treatment of tuberculous aortic pseudoaneurysm.

Authors:  Shinichiro Ikeda; Michael Shih; Antonios Likourezos; Peter Flom; Robert Y Rhee; Benjamin A Youdelman
Journal:  J Card Surg       Date:  2018-12       Impact factor: 1.620

Review 2.  Arteriocutaneous Fistula Associated with Bilateral Femoral Pseudoaneurysms Caused by Bacillus Calmette-Guérin. Apropos of a Case and Review of Literature.

Authors:  Álvaro Torres-Blanco; Francisco Gómez-Palonés; Gemma Edo-Fleta
Journal:  Ann Vasc Surg       Date:  2016-11-27       Impact factor: 1.466

3.  Tuberculosis contact investigation in low prevalence countries: a European consensus.

Authors:  C G M Erkens; M Kamphorst; I Abubakar; G H Bothamley; D Chemtob; W Haas; G B Migliori; H L Rieder; J-P Zellweger; C Lange
Journal:  Eur Respir J       Date:  2010-10       Impact factor: 16.671

4.  Mycotic abdominal aortic aneurysm after adjuvant therapy with bacillus Calmette-Guérin in patients with urothelial bladder cancer: a rare but misinterpreted complication.

Authors:  Enrico Leo; Alessandro L C Molinari; Giovanni Rossi; Stefano A Ferrari; Angelo Terzi; Giovanni Lorenzi
Journal:  Ann Vasc Surg       Date:  2015-06-24       Impact factor: 1.466

Review 5.  Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience.

Authors:  R Long; R Guzman; H Greenberg; J Safneck; E Hershfield
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

6.  BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.

Authors:  P D Hart; I Sutherland
Journal:  Br Med J       Date:  1977-07-30

7.  Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.

Authors:  A Morales; D Eidinger; A W Bruce
Journal:  J Urol       Date:  1976-08       Impact factor: 7.450

8.  Endovascular treatment of infected aortic aneurysms.

Authors:  P Sedivy; M Spacek; K El Samman; O Belohlavek; T Mach; V Jindrak; V Rohn; P Stadler
Journal:  Eur J Vasc Endovasc Surg       Date:  2012-08-20       Impact factor: 7.069

9.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

10.  Fluorescence in situ hybridization microscopic detection of Bacilli Calmette Guérin mycobacteria in aortic lesions: A case report.

Authors:  Florent Darriet; Paola Bernioles; Ahmed Loukil; Nadia Saidani; Carole Eldin; Michel Drancourt
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.